Brighton Jones LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $300K | Sell |
571
-432
| -43% | -$227K | 0.01% | 719 |
|
|
2025
Q1 | $636K | Buy |
1,003
+55
| +6% | +$34.9K | 0.02% | 331 |
|
|
2024
Q4 | $675K | Buy |
948
+686
| +262% | +$489K | 0.02% | 328 |
|
|
2024
Q3 | $275K | Sell |
262
-658
| -72% | -$691K | 0.01% | 451 |
|
|
2024
Q2 | $967K | Buy |
920
+14
| +2% | +$14.7K | 0.03% | 232 |
|
|
2024
Q1 | $872K | Sell |
906
-33
| -4% | -$31.8K | 0.03% | 246 |
|
|
2023
Q4 | $825K | Sell |
939
-2
| -0.2% | -$1.76K | 0.03% | 235 |
|
|
2023
Q3 | $774K | Buy |
941
+54
| +6% | +$44.4K | 0.04% | 217 |
|
|
2023
Q2 | $637K | Sell |
887
-28
| -3% | -$20.1K | 0.03% | 258 |
|
|
2023
Q1 | $752K | Sell |
915
-10
| -1% | -$8.22K | 0.04% | 217 |
|
|
2022
Q4 | $667K | Sell |
925
-9
| -1% | -$6.49K | 0.04% | 204 |
|
|
2022
Q3 | $643K | Sell |
934
-9
| -1% | -$6.2K | 0.04% | 207 |
|
|
2022
Q2 | $557K | Sell |
943
-59
| -6% | -$34.8K | 0.03% | 231 |
|
|
2022
Q1 | $700K | Buy |
1,002
+192
| +24% | +$134K | 0.03% | 221 |
|
|
2021
Q4 | $512K | Buy |
810
+201
| +33% | +$127K | 0.02% | 275 |
|
|
2021
Q3 | $369K | Buy |
609
+53
| +10% | +$32.1K | 0.02% | 321 |
|
|
2021
Q2 | $311K | Buy |
556
+74
| +15% | +$41.4K | 0.02% | 347 |
|
|
2021
Q1 | $228K | Sell |
482
-132
| -21% | -$62.4K | 0.01% | 370 |
|
|
2020
Q4 | $297K | Buy |
614
+203
| +49% | +$98.2K | 0.02% | 292 |
|
|
2020
Q3 | $230K | Buy |
+411
| New | +$230K | 0.02% | 292 |
|
|
2014
Q4 | – | Sell |
-970
| Closed | -$350K | – | 209 |
|
|
2014
Q3 | $350K | Hold |
970
| – | – | 0.08% | 132 |
|
|
2014
Q2 | $274K | Hold |
970
| – | – | 0.06% | 146 |
|
|
2014
Q1 | $291K | Hold |
970
| – | – | 0.07% | 136 |
|
|
2013
Q4 | $267K | Sell |
970
-53
| -5% | -$14.6K | 0.06% | 144 |
|
|
2013
Q3 | $320K | Buy |
+1,023
| New | +$320K | 0.08% | 110 |
|